Recombinant Anti-HER1 x Anti-HER3 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-HER1 IgG with similar domains from an anti-HER3 antibody via short peptide linkers, or vice versa. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Head and neck cancer; Colorectal cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-HER1 x Anti-HER3 Bispecific Antibody (Fv-IgG) (BSDG-165). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS